- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.20 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x NDP: NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)
- 4 x PT6: 1-(3-amino-2-methylbenzyl)-4-[2-(thiophen-2-yl)ethoxy]pyridin-2(1H)-one(Non-covalent)
PT6.2: 14 residues within 4Å:- Chain A: A.121, F.122, A.123, L.128, Y.173, V.180, Q.181, Y.183, M.186, P.218, S.223, F.230, I.233
- Ligands: NDP.1
11 PLIP interactions:11 interactions with chain A- Hydrophobic interactions: A:A.121, A:L.128, A:Y.173, A:V.180, A:Y.183, A:Y.183, A:P.218, A:I.233
- Hydrogen bonds: A:A.123, A:A.123, A:Y.183
PT6.5: 17 residues within 4Å:- Chain B: A.121, F.122, A.123, L.128, Y.173, V.180, Q.181, Y.183, M.186, P.218, S.223, A.224, V.227, G.228, F.230, I.233
- Ligands: NDP.4
11 PLIP interactions:11 interactions with chain B- Hydrophobic interactions: B:L.128, B:Y.173, B:V.180, B:Y.183, B:Y.183, B:P.218, B:A.224, B:I.233
- Hydrogen bonds: B:A.123, B:A.123
- pi-Stacking: B:Y.183
PT6.9: 19 residues within 4Å:- Chain C: A.121, F.122, A.123, M.125, L.128, Y.173, V.180, Q.181, Y.183, M.186, P.218, S.223, A.224, V.227, G.228, G.229, F.230, I.233
- Ligands: NDP.8
12 PLIP interactions:12 interactions with chain C- Hydrophobic interactions: C:L.128, C:Y.173, C:V.180, C:Y.183, C:P.218, C:A.224, C:F.230, C:F.230
- Hydrogen bonds: C:A.123, C:A.123, C:Y.183
- pi-Stacking: C:Y.183
PT6.12: 15 residues within 4Å:- Chain D: A.121, F.122, A.123, L.128, Y.173, V.180, Q.181, Y.183, M.186, P.218, S.223, V.227, F.230, I.233
- Ligands: NDP.11
10 PLIP interactions:10 interactions with chain D- Hydrophobic interactions: D:L.128, D:Y.173, D:V.180, D:Y.183, D:P.218, D:F.230, D:I.233
- Hydrogen bonds: D:A.123, D:A.123
- pi-Stacking: D:Y.183
- 3 x SO4: SULFATE ION(Non-functional Binders)
SO4.3: 6 residues within 4Å:- Chain A: V.227, G.228, G.229, F.230, N.231, T.232
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:N.231, A:T.232, A:T.232
SO4.6: 6 residues within 4Å:- Chain B: V.227, G.228, G.229, F.230, N.231, T.232
4 PLIP interactions:4 interactions with chain B- Hydrogen bonds: B:G.229, B:G.229, B:N.231, B:T.232
SO4.10: 6 residues within 4Å:- Chain C: V.227, G.228, G.229, F.230, N.231, T.232
5 PLIP interactions:5 interactions with chain C- Hydrogen bonds: C:G.229, C:F.230, C:N.231, C:T.232, C:T.232
- 2 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Schiebel, J. et al., Rational Design of Broad Spectrum Antibacterial Activity Based on a Clinically Relevant Enoyl-Acyl Carrier Protein (Acp) Reductase Inhibitor. J.Biol.Chem. (2014)
- Release Date
- 2014-04-16
- Peptides
- ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTASE [NADPH]: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.20 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x NDP: NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)
- 4 x PT6: 1-(3-amino-2-methylbenzyl)-4-[2-(thiophen-2-yl)ethoxy]pyridin-2(1H)-one(Non-covalent)
- 3 x SO4: SULFATE ION(Non-functional Binders)
- 2 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Schiebel, J. et al., Rational Design of Broad Spectrum Antibacterial Activity Based on a Clinically Relevant Enoyl-Acyl Carrier Protein (Acp) Reductase Inhibitor. J.Biol.Chem. (2014)
- Release Date
- 2014-04-16
- Peptides
- ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTASE [NADPH]: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D